The Rise in Tianeptine Abuse: Our Next Kratom Problem?

dc.contributor.authorBettinger, Jeffrey J.
dc.contributor.authorCleary, Jacqueline H.
dc.contributor.orcidhttps://orcid.org/0000-0001-5846-6741
dc.date.accessioned2025-01-31T18:01:28Z
dc.date.available2025-01-31T18:01:28Z
dc.date.issued2020-09-16
dc.descriptionClick on the Resource Link to access the article (may not be free).
dc.description.abstractClinicians should be aware of this easily purchased tricyclic-like antidepressant and its opioid-like risks.
dc.description.urihttps://www.practicalpainmanagement.com/treatments/addiction-medicine/rise-tianeptine-abuse-our-next-kratom-problem
dc.identifier.citationBettinger, Jeffrey J., and Jacqueline Cleary. “The Rise in Tianeptine Abuse: Our Next Kratom Problem?” Practical Pain Management, vol. 20, no. 2, 2020, pp. 61–64., https://www.practicalpainmanagement.com/treatments/addiction-medicine/rise-tianeptine-abuse-our-next-kratom-problem.
dc.identifier.issn1541-5988
dc.identifier.urihttps://hdl.handle.net/20.500.14303/669
dc.language.isoen
dc.publisherRemedy Health Media
dc.relation.ispartofPractical Pain Management
dc.rightsThis Item is protected by copyright and/or related rights. You are free to use this Item in any way that is permitted by the copyright and related rights legislation that applies to your use. For other uses you need to obtain permission from the rights-holder(s). http://rightsstatements.org/vocab/InC/1.0/
dc.subjecttianeptine
dc.subjectMitragyna
dc.subjectAnalgesics, Opioid
dc.subjectAntidepressive Agents
dc.titleThe Rise in Tianeptine Abuse: Our Next Kratom Problem?
dc.typeArticle
local.departmentprogramDepartment of Pharmacy Practice
Files